Tesamorelin 5mg | 10-Vial Kit | GHRH Analog | Egrifta

Tesamorelin 5mg | 10-Vial Kit | GHRH Analog | Egrifta

$100.00

Tesamorelin (GHRH(1-44) analog — FDA-approved Egrifta) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.

Category: Peptides

Description
Reviews (0)

Description

What is Tesamorelin?

Tesamorelin is a stabilised full-length GHRH(1-44) analog — the only GHRH analog with FDA approval (Egrifta, 2010) for HIV-associated lipodystrophy. Full GHRH(1-44) sequence provides superior GHRHR binding vs sermorelin (1-29 fragment). Stimulates pulsatile GH release → IGF-1 → visceral fat reduction. Falutz 2010 (NEJM): 15.2% visceral fat reduction vs +5.0% placebo.